Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917558736> ?p ?o ?g. }
- W2917558736 endingPage "202" @default.
- W2917558736 startingPage "197" @default.
- W2917558736 abstract "Objective To review the evidence for benefits and harms of folate (folic acid or folinic acid) supplementation on methotrexate (MTX) treatment for rheumatoid arthritis (RA), to assess whether or not folate supplementation would reduce MTX toxicity or reduce MTX benefits, and to decide whether a higher MTX dosage is essential. Methods We performed a sensitive search strategy and searched systematically the Medline, Embase, Web of Science and Cochrane Library databases from inception to 2 June 2016. Abstracts from major rheumatology meetings and major trial registers were also searched to retrieve all randomized controlled trials that interested us. Results Seven studies with 709 patients were included. No significant heterogeneity was found between these trials. For RA patients treated with MTX, those supplied with folate were less likely to have elevated transaminase (odds ratio [OR] 0.15; 95% confidence interval [95% CI] 0.10, 0.23 [ p < 0.00001]) and gastrointestinal side-effects such as nausea and vomiting (OR 0.71; 95% CI 0.51, 0.99 [ p = 0.04]). Folate appeared to promote compliance to MTX as it reduced patient withdrawal compared to placebo (OR 0.29; 95% CI 0.21, 0.42 [ p < 0.00001]). There was no statistical difference for mouth sores between folate and placebo (OR 0.83; 95% CI 0.57, 1.22 [ p = 0.35]). As the markers of disease activity in those trials were not consistent, it was impossible to decide whether folate supplementation reduced MTX efficacy. Besides, we compared high-dose folate (≥25 mg per week) and low-dose folate (≤10 mg per week) on MTX efficacy, finding no statistical difference (OR 2.07; 95% CI 0.81, 5.30 [ p = 0.13]), nor on MTX toxicity (OR 1.56; 95% CI 0.80,3.04 [ p = 0.19]). Conclusion Folate supplementation can reduce the incidence of hepatotoxicity and gastrointestinal side-effects of MTX in patients with RA. It can also reduce patient withdrawal from MTX treatment. Although it tended to reduce mouth sores, it had no statistical significance. No significant difference was found between high-dose folate and low-dose folate on MTX efficacy or toxicity." @default.
- W2917558736 created "2019-03-02" @default.
- W2917558736 creator A5002907962 @default.
- W2917558736 creator A5008550633 @default.
- W2917558736 creator A5008741815 @default.
- W2917558736 creator A5020579375 @default.
- W2917558736 creator A5020856857 @default.
- W2917558736 creator A5041329689 @default.
- W2917558736 creator A5046078938 @default.
- W2917558736 creator A5046612613 @default.
- W2917558736 creator A5054941753 @default.
- W2917558736 creator A5067740994 @default.
- W2917558736 creator A5069998769 @default.
- W2917558736 creator A5079244166 @default.
- W2917558736 creator A5081493863 @default.
- W2917558736 date "2018-07-03" @default.
- W2917558736 modified "2023-10-03" @default.
- W2917558736 title "Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis" @default.
- W2917558736 cites W1522182824 @default.
- W2917558736 cites W1629644215 @default.
- W2917558736 cites W1981680557 @default.
- W2917558736 cites W2002265278 @default.
- W2917558736 cites W2013864512 @default.
- W2917558736 cites W2015228675 @default.
- W2917558736 cites W2024197152 @default.
- W2917558736 cites W2064119537 @default.
- W2917558736 cites W2066203563 @default.
- W2917558736 cites W2073564793 @default.
- W2917558736 cites W2088761837 @default.
- W2917558736 cites W2116843833 @default.
- W2917558736 cites W2122917464 @default.
- W2917558736 cites W2146502982 @default.
- W2917558736 cites W2152348310 @default.
- W2917558736 cites W2165010366 @default.
- W2917558736 cites W2184889105 @default.
- W2917558736 cites W3023552461 @default.
- W2917558736 doi "https://doi.org/10.1097/rhu.0000000000000810" @default.
- W2917558736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29975207" @default.
- W2917558736 hasPublicationYear "2018" @default.
- W2917558736 type Work @default.
- W2917558736 sameAs 2917558736 @default.
- W2917558736 citedByCount "26" @default.
- W2917558736 countsByYear W29175587362019 @default.
- W2917558736 countsByYear W29175587362020 @default.
- W2917558736 countsByYear W29175587362021 @default.
- W2917558736 countsByYear W29175587362022 @default.
- W2917558736 countsByYear W29175587362023 @default.
- W2917558736 crossrefType "journal-article" @default.
- W2917558736 hasAuthorship W2917558736A5002907962 @default.
- W2917558736 hasAuthorship W2917558736A5008550633 @default.
- W2917558736 hasAuthorship W2917558736A5008741815 @default.
- W2917558736 hasAuthorship W2917558736A5020579375 @default.
- W2917558736 hasAuthorship W2917558736A5020856857 @default.
- W2917558736 hasAuthorship W2917558736A5041329689 @default.
- W2917558736 hasAuthorship W2917558736A5046078938 @default.
- W2917558736 hasAuthorship W2917558736A5046612613 @default.
- W2917558736 hasAuthorship W2917558736A5054941753 @default.
- W2917558736 hasAuthorship W2917558736A5067740994 @default.
- W2917558736 hasAuthorship W2917558736A5069998769 @default.
- W2917558736 hasAuthorship W2917558736A5079244166 @default.
- W2917558736 hasAuthorship W2917558736A5081493863 @default.
- W2917558736 hasConcept C126322002 @default.
- W2917558736 hasConcept C142724271 @default.
- W2917558736 hasConcept C156957248 @default.
- W2917558736 hasConcept C168563851 @default.
- W2917558736 hasConcept C204787440 @default.
- W2917558736 hasConcept C27081682 @default.
- W2917558736 hasConcept C2776478404 @default.
- W2917558736 hasConcept C2776694085 @default.
- W2917558736 hasConcept C2777077863 @default.
- W2917558736 hasConcept C2777575956 @default.
- W2917558736 hasConcept C2779804826 @default.
- W2917558736 hasConcept C2780456651 @default.
- W2917558736 hasConcept C2780580376 @default.
- W2917558736 hasConcept C2781059491 @default.
- W2917558736 hasConcept C44249647 @default.
- W2917558736 hasConcept C71924100 @default.
- W2917558736 hasConcept C90924648 @default.
- W2917558736 hasConcept C95190672 @default.
- W2917558736 hasConceptScore W2917558736C126322002 @default.
- W2917558736 hasConceptScore W2917558736C142724271 @default.
- W2917558736 hasConceptScore W2917558736C156957248 @default.
- W2917558736 hasConceptScore W2917558736C168563851 @default.
- W2917558736 hasConceptScore W2917558736C204787440 @default.
- W2917558736 hasConceptScore W2917558736C27081682 @default.
- W2917558736 hasConceptScore W2917558736C2776478404 @default.
- W2917558736 hasConceptScore W2917558736C2776694085 @default.
- W2917558736 hasConceptScore W2917558736C2777077863 @default.
- W2917558736 hasConceptScore W2917558736C2777575956 @default.
- W2917558736 hasConceptScore W2917558736C2779804826 @default.
- W2917558736 hasConceptScore W2917558736C2780456651 @default.
- W2917558736 hasConceptScore W2917558736C2780580376 @default.
- W2917558736 hasConceptScore W2917558736C2781059491 @default.
- W2917558736 hasConceptScore W2917558736C44249647 @default.
- W2917558736 hasConceptScore W2917558736C71924100 @default.
- W2917558736 hasConceptScore W2917558736C90924648 @default.
- W2917558736 hasConceptScore W2917558736C95190672 @default.
- W2917558736 hasIssue "5" @default.